AstraZeneca and GlaxoSmithKline are about to issue their full year results

Issue Contents

Editor's View
Feature
Funds
Great Ideas
Investment Trusts
News
Personal Finance
Under The Bonnet
Week Ahead

Issue Contents

Editor's View
Feature
Funds
Great Ideas
Investment Trusts
News
Personal Finance
Under The Bonnet
Week Ahead